Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Liver Diseases

Free Subscription 09.02.2026 2 Am J Gastroenterol 1 Anticancer Res 3 Biochem Biophys Res Commun 1 BMC Cancer 3 BMC Gastroenterol 1 Cancer 5 Clin Res Hepatol Gastroenterol 1 Dig Dis Sci 1 Endoscopy 1 Eur J Pediatr 1 Eur Radiol 1 Gastroenterology 1 Gut 5 Hepatology 1 Int J Cancer 1 J Comput Assist Tomogr 1 J Gastroenterol 4 J Gastroenterol Hepatol 4 J Hepatol 1 J Pediatr Surg 1 PLoS Med 7 PLoS One 1 Proc Natl Acad Sci U S A 1 Radiol Imaging Cancer 1 Radiology 4 Transplant Proc 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. CAVIGLIA GP, Ferro A, D'Ambrosio R, Perbellini R, et al
   Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study.
   Am J Gastroenterol. 2026;121:375-382.
   PubMed         Abstract available
   
   
2. ALKHOURI N, Cheuk-Fung Yip T, Castera L, Takawy M, et al
   ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease.
   Am J Gastroenterol. 2026;121:362-374.
   PubMed         Abstract available
   
   

   
   Anticancer Res

3. MATSUI S, Kato Y, Ohgi K, Ashida R, et al
   Clinical Relevance of the CALLY Index in Prognostic Stratification of Intrahepatic Cholangiocarcinoma.
   Anticancer Res. 2026;46:963-974.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

4. KIM HW, Kim J, Ko JH, Kang JG, et al
   RALY promotes Epithelial-mesenchymal transition in Hepatocellular carcinoma by regulating Snail.
   Biochem Biophys Res Commun. 2026;805:153402.
   PubMed         Abstract available
   
   
5. MO J, Liu Z, Fu J, Ge Q, et al
   Proline metabolism supports the hepatocellular carcinoma cell survival by mitigating ROS generation under nutrient starvation.
   Biochem Biophys Res Commun. 2026;805:153392.
   PubMed         Abstract available
   
   
6. HWANG HS, Kim MJ, Kim SE, Choi EK, et al
   Laminarin ameliorates hepatic steatosis and upregulates hepatic SMP-30 expression in high-fat-diet-induced NAFLD mice.
   Biochem Biophys Res Commun. 2026;805:153359.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. NI Z, Gu J, Qiu Q, Li Y, et al
   Integrated and clinical validation of helicase-like transcription factor as a biomarker for hepatocellular carcinoma.
   BMC Cancer. 2026 Feb 2. doi: 10.1186/s12885-026-15652.
   PubMed        
   
   

   
   BMC Gastroenterol

8. ZHANG L, Yuan J, Liu S, Zhang L, et al
   Analysis of survival prognosis and influencing factors in patients with primary liver cancer after D-TACE: a retrospective cohort study.
   BMC Gastroenterol. 2026;26:93.
   PubMed         Abstract available
   
   
9. JIN M, Zhou J, He DM, Chen FL, et al
   Risk factors for significant hepatic fibrosis in alcoholic liver disease and construction of a nomogram prediction model.
   BMC Gastroenterol. 2026 Feb 2. doi: 10.1186/s12876-026-04606.
   PubMed        
   
   
10. KWAK JY, Jeon H, Kwon HU, Kim JE, et al
    Recompensation following first decompensation in patients with alcohol-related cirrhosis.
    BMC Gastroenterol. 2026 Feb 2. doi: 10.1186/s12876-026-04651.
    PubMed        
    
    

    
    Cancer

11. LUO J, Li Z, Ge J, Cai S, et al
    Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma: A cost-effectiveness analysis.
    Cancer. 2026;132:e70259.
    PubMed         Abstract available
    
    

    
    Clin Res Hepatol Gastroenterol

12. TIROTTA D, Lena C, Torre M, Muratori P, et al
    Hematologic Focal Hepatic Lesions in the Absence of Liver Cirrhosis: Consider Lymphoma and Myeloma.
    Clin Res Hepatol Gastroenterol. 2025 Dec 16:102749.
    PubMed         Abstract available
    
    
13. FU J, Chen J, Jin L, Huang J, et al
    Comparison of repeat hepatectomy with radiofrequency ablation for the survival of hepatocellular carcinoma with solitary intrahepatic recurrence after hepatectomy.
    Clin Res Hepatol Gastroenterol. 2026;50:102750.
    PubMed         Abstract available
    
    
14. DING C, Xing Y, Liang S, Wang C, et al
    Rifaximin for Primary prophylaxis of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: A cohort analysis.
    Clin Res Hepatol Gastroenterol. 2026;50:102751.
    PubMed         Abstract available
    
    
15. BEYENE E, Chirumamilla L, Bisrat M, Bowen A, et al
    Liver gains beyond glycemic control: GLP-1 vs. SGLT2 in metabolic dysfunction-associated steatohepatitis (MASH): A real-world data analysis.
    Clin Res Hepatol Gastroenterol. 2026;50:102760.
    PubMed         Abstract available
    
    
16. LE CALVEZ F, King J, Couret A, Abergel A, et al
    Associations of episodic and tonic appetite-related signals with malnutrition and appetite dysregulation in end-stage liver disease.
    Clin Res Hepatol Gastroenterol. 2026;50:102765.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

17. JIANG Z, Zhang J, Zhang X, Xie C, et al
    Comment on "Agile 3 + and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLD".
    Dig Dis Sci. 2026 Feb 4. doi: 10.1007/s10620-026-09726.
    PubMed        
    
    

    
    Endoscopy

18. NI J, Su G, Xu K, Gong X, et al
    Endoscopic ultrasound-guided dual-route recanalization of isolated hepatic ducts following complete hilar disconnection.
    Endoscopy. 2026;58.
    PubMed        
    
    

    
    Eur J Pediatr

19. CAMPOS LR, Khalil SM, Souza M
    The epidemiology of metabolic dysfunction-associated steatotic liver disease among pediatric patients with type 2 diabetes: Systematic review and meta-analysis.
    Eur J Pediatr. 2026;185:120.
    PubMed         Abstract available
    
    

    
    Eur Radiol

20. PAGE G, Garteiser P, Paradis V, Sartoris R, et al
    MR elastography in patients with hepatocellular carcinoma: tumor stiffening during compression induced by respiration to assess microvascular invasion.
    Eur Radiol. 2026 Feb 1. doi: 10.1007/s00330-025-12164.
    PubMed         Abstract available
    
    

    
    Gastroenterology

21. MULLISH BH
    Improving efficacy without increasing side effects? Exploring the impact of a novel GLP-1-glucagon dual receptor agonist upon metabolic dysfunction-associated steatohepatitis.
    Gastroenterology. 2026 Jan 29:S0016-5085(26)00083.
    PubMed        
    
    

    
    Gut

22. ROMEO M, Dallio M, Di Nardo F, Napolitano C, et al
    Beyond gastrointestinal symptom burden: exploring the impact of previous cholecystectomy on ultrasound-based hepatocellular carcinoma surveillance in patients with liver cirrhosis.
    Gut. 2026 Feb 3:gutjnl-2026-338023. doi: 10.1136/gutjnl-2026-338023.
    PubMed        
    
    

    
    Hepatology

23. CHOI J, Xu J, Nguyen VH, Przybyszewski E, et al
    Association between statin use and hepatic decompensation in patients with primary biliary cholangitis: A target trial emulation study.
    Hepatology. 2026 Feb 2. doi: 10.1097/HEP.0000000000001701.
    PubMed         Abstract available
    
    
24. WEI JX, Lv LH, Wan YL, Cao Y, et al
    Erratum: Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells.
    Hepatology. 2026 Feb 5. doi: 10.1097/HEP.0000000000001667.
    PubMed        
    
    
25. LEUNG KK, Li W, Hansen B, Gulamhusein A, et al
    Understanding hepatopancreatobiliary cancer risks in a population-based primary sclerosing cholangitis-inflammatory bowel disease cohort.
    Hepatology. 2026 Feb 4. doi: 10.1097/HEP.0000000000001692.
    PubMed         Abstract available
    
    
26. YANG X, Yang N, Cheng Z, Zhang R, et al
    Hepatic GPR75 exacerbates MASH through GNAI2-Dependent signaling.
    Hepatology. 2026 Feb 3. doi: 10.1097/HEP.0000000000001706.
    PubMed         Abstract available
    
    
27. HU X, Zhang Q, Wan L, Liu M, et al
    Letter to the editor: Hepatocyte-derived extracellular vesicles promote endothelial pyroptosis in chronic liver disease: Undefined role of miR-153-3p.
    Hepatology. 2026 Feb 2. doi: 10.1097/HEP.0000000000001702.
    PubMed        
    
    

    
    Int J Cancer

28. WATLING CZ, Campbell PT, Graubard BI, Wang Y, et al
    Pre-diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case-control analysis of 12 prospective cohorts.
    Int J Cancer. 2026;158:1801-1812.
    PubMed         Abstract available
    
    

    
    J Comput Assist Tomogr

29. HAN L, Zhang T, Liu X, Ji Q, et al
    Extended Validity of Hematocrit for Dual-energy CT Extracellular Volume Calculation in Cirrhosis: A 7-Day Window Enhances Clinical Utility.
    J Comput Assist Tomogr. 2026 Jan 30. doi: 10.1097/RCT.0000000000001847.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

30. IMAOKA K, Ohira M, Yano T, Bekki T, et al
    Intestinal obstruction impairs the antitumor function of hepatic natural killer cells against colorectal cancer.
    J Gastroenterol. 2026 Feb 6. doi: 10.1007/s00535-026-02349.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

31. JANG TY
    Interaction Between Genetic Variants and Air Pollution and the Risk of Hepatocellular Carcinoma in Cirrhotic Patients.
    J Gastroenterol Hepatol. 2026 Feb 6. doi: 10.1111/jgh.70282.
    PubMed        
    
    
32. NISHIDA H
    Comment on "Helicobacter pylori Screening and Eradication in Junior High School Students in Yokosuka, Japan: Prevalence, Eradication Rates, and Challenges" (J Gastroenterol Hepatol 2025; 40:2499-2506).
    J Gastroenterol Hepatol. 2026 Feb 6. doi: 10.1111/jgh.70284.
    PubMed        
    
    
33. AHMED N, Riaz A, Ahmed BB, Noorzai R, et al
    Comment on "Role of ALBI Grade as a Predictive Factor for Long-Term Mortality in Patients With Hepatocellular Carcinoma (HCC) Undergoing Trans-Arterial Chemoembolization (TACE)".
    J Gastroenterol Hepatol. 2026 Feb 4. doi: 10.1111/jgh.70243.
    PubMed        
    
    
34. FARAH H, Kadhim-Abosaoda M, Mohaisen-Mousa H, Jyothi R, et al
    Exosome-Based Strategies in Hepatocellular Carcinoma: Mechanisms, Immunotherapy, and Clinical Challenges.
    J Gastroenterol Hepatol. 2026 Feb 2. doi: 10.1111/jgh.70245.
    PubMed         Abstract available
    
    

    
    J Hepatol

35. PINTER M, Iavarone M
    Reversing the global burden of hepatocellular carcinoma.
    J Hepatol. 2026 Feb 2:S0168-8278(26)00057-7. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
36. CLUSMANN J, Kather JN
    Author response: Language barriers for adoption of artificial intelligence in hepatology.
    J Hepatol. 2026 Feb 2:S0168-8278(26)00059-0. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
37. CHEW V
    Hepatic zonation as the gatekeeper of beta-catenin oncogenic transformation.
    J Hepatol. 2026 Feb 4:S0168-8278(26)00010-3. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
38. LI B, Guo R, Wang S, Zhang J, et al
    IL22 supports Long-Term Expansion of Mouse and Human Hepatocytes.
    J Hepatol. 2026 Feb 3:S0168-8278(26)00056-5. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    

    
    J Pediatr Surg

39. LU Z, Zhu Y, Ding Z, Zhang R, et al
    Hepatic CMV-IE expression and distribution further defines the aetiological and prognostic subtypes of biliary atresia.
    J Pediatr Surg. 2026 Feb 2:162940. doi: 10.1016/j.jpedsurg.2026.162940.
    PubMed         Abstract available
    
    

    
    PLoS Med

40. LI ZY, Li HL, Wang J, Shen QM, et al
    Metabolomic insights into associations between adiposity markers and liver cancer risk: Results from a prospective cohort study and Mendelian randomization analysis.
    PLoS Med. 2026;23:e1004910.
    PubMed         Abstract available
    
    

    
    PLoS One

41. KITAGATAYA T, Krishnan A, Olson KE, Gutierrez F, et al
    Genetic ablation of interleukin-17A augments fibrosis in a mouse model of cholestatic liver injury.
    PLoS One. 2026;21:e0342251.
    PubMed         Abstract available
    
    
42. CHEN R, Sun Y, Tai W
    A multifaceted analysis of OTUD5 integrated MAVS in innate immunity of Primary Biliary Cholangitis.
    PLoS One. 2026;21:e0342306.
    PubMed         Abstract available
    
    
43. METTANANDA C, Ranawaka C, Egodage T, Dantanarayana C, et al
    Adoption and validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic dysfunction-associated steatotic liver disease in low-resource South Asian settings.
    PLoS One. 2026;21:e0341364.
    PubMed         Abstract available
    
    
44. ZHANG XF, Zhang XL, Xu HW, Lin YH, et al
    ITIH2 in colorectal cancer metastasis: Weighted Gene Co-expression Network Analysis-guided functional validation.
    PLoS One. 2026;21:e0329719.
    PubMed         Abstract available
    
    
45. WANG X, Ma R, Lou D, Li H, et al
    Ursolic acid alleviates liver injury in diabetic mice induced by high-fat diet combined with streptozotocin via the NLRP3 signaling pathway.
    PLoS One. 2026;21:e0340643.
    PubMed         Abstract available
    
    
46. ZHU G, Qu Y, Chen K, He D, et al
    Comparison of the triglyceride-glucose index and triglyceride-glucose-body mass index for predicting non-alcoholic fatty liver disease in elderly diabetic patients.
    PLoS One. 2026;21:e0341109.
    PubMed         Abstract available
    
    
47. ZHANG X, Cheng Y, Yu R, Hu X, et al
    Single cell RNA sequencing analysis and molecular biology experiments identify NAFLD-related fibroblasts and highlights seven hub genes in NAFLD.
    PLoS One. 2026;21:e0332881.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

48. ZHANG L, Ren C, He M, Chen X, et al
    Mitochondrial transfer in the HSC-HCC-macrophage network shapes hepatocellular carcinoma progression.
    Proc Natl Acad Sci U S A. 2026;123:e2512592123.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

49. SARTORIS R, Paisant A, Bone A, Nicolas F, et al
    A Deep Learning Algorithm for Liver Metastasis Detection at Contrast-enhanced Abdominal CT in Patients with Colorectal Cancer: A Comparative Study with Radiologists.
    Radiol Imaging Cancer. 2026;8:e250242.
    PubMed         Abstract available
    
    

    
    Radiology

50. QI BN, Zhao XY, Lv WJ, Shan S, et al
    Nodular Transformation-driven Circulatory Remodeling in Biliary Atresia-induced Pediatric Biliary Cirrhosis: A Three-dimensional Phase-Contrast CT Rendering.
    Radiology. 2026;318:e252332.
    PubMed         Abstract available
    
    

    
    Transplant Proc

51. REJON-LOPEZ R, Santidrian-Zurbano M, Vico-Arias AB, Mohamed-Chairi MH, et al
    Liver Transplantation in Patients With Hepatocarcinoma. Does the Donor Characteristics Influence the Risk of Tumor Recurrence and Survival?
    Transplant Proc. 2026 Feb 4:S0041-1345(26)00053.
    PubMed         Abstract available
    
    
52. BARNHILL MS, Chascsa DM, McHugh K, Nagarakanti SR, et al
    Simultaneous Liver and Kidney Transplantation for Cirrhosis Directly Attributed to Disseminated Hepatic Coccidioidomycosis.
    Transplant Proc. 2026 Feb 4:S0041-1345(26)00028.
    PubMed         Abstract available
    
    
53. NAKAYAMA Y, Toshima T, Itoh S, Motomura T, et al
    Risks of Early Graft Loss in Living Donor Liver Transplantation for Patients With a Low Model for End-Stage Liver Disease Score: Is It Truly Safe?
    Transplant Proc. 2026 Jan 6:S0041-1345(25)00605.
    PubMed         Abstract available
    
    
54. WANG R, Jiang X, Zhang W
    Case Report: Fospropofol Disodium for Anesthesia Induction in Liver Transplant Recipients - A Case Series.
    Transplant Proc. 2026 Jan 8:S0041-1345(25)00582.
    PubMed         Abstract available
    
    

    
    Transplantation

55. MUFTI A, Farr M
    Cirrhotic Cardiomyopathy: Moving From Description to Intervention.
    Transplantation. 2026 Feb 3. doi: 10.1097/TP.0000000000005655.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum